Nasdaq Drops Gene Logic from Biotech Index | GenomeWeb
NEW YORK (GenomeWeb News) - Nasdaq said Friday that it has dropped Gene Logic from its Biotechnology Index after a semi-annual review of biotechnology companies.
 
According to the Nasdaq website, companies listed on the Biotechnology Index must maintain a market capitalization value of more than $200 million, an average daily trading volume of at least 100,000 shares, and must meet certain other criteria.
 
Gene Logic's market cap is currently listed at $48.6 million with volume of 15,872 shares.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.